For questions
about MDGs, please contact the CTO Senior Director at
Cynthia.Gifford-Hollingsworth@jefferson.edu
The MDG is the
first committee that will review an oncology-related study. Note that
retrospective chart reviews and correlative lab trials that will utilize
banked blood and tissue that do not require informed consent are exempt from
MDG review and approval.
The purpose of
the MDG is to prioritize and oversee the operations and management of
clinical research being conducted within their specific group. There are 7
designated disease groups, and each of them has their own MDG committee. Each
committee has a committee leader and a minimum of one co-leader, as well as
an MDG coordinator.
There is a
specific timeframe in which protocols need to be submitted to the MDG
coordinator, and a specific review process. An approval notification is
provided.
Institutional
Review Board submission preparation should begin after this committee
approval is received.
|